Security key
92941V308
VYNE Therapeutics Inc. - common stock, par value $0.0001 (VYNE)
CUSIP: 92941V308
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / common stock, par value $0.0001
- Total 13F shares
- 8,179,397
- Total 13F value
- $4,743,526
- Share change
- +2,809,841
- SEC-reported price per share
- $0.58
- Number of holders
- 39
- Value change
- +$1,869,192
- Number of buys
- 19
- Number of sells
- 10
- Shares outstanding
- 33,403,382
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
39
Top holders
10
VYNE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
VYNE Therapeutics Inc. SEC filings
VYNE Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92941V308
Recent filing periods:
Ownership snapshot
Top reported holders of VYNE - VYNE Therapeutics Inc. - common stock, par value $0.0001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CITADEL ADVISORS LLC
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G
13F
Lead comparable stake: 0.01%
13D/G row: CITADEL ADVISORS LLC
Showing 1-6 of 15 holder rows.
Quick read
CITADEL ADVISORS LLC leads the comparable SEC ownership view at 0.01%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CITADEL ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
CITADEL ADVISORS LLC
0.01%
BAKER BROS. ADVISORS LP
2.5%
ACORN CAPITAL ADVISORS, LLC
1.8%
Shay Capital LLC
1.5%
ACADIAN ASSET MANAGEMENT LLC
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC |
13D/G
Kenneth Griffin
|
0.01%
|
$1,250
3,732 shares
|
-$367,360 | 30 Sep 2025 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
2.5%
|
$285,203
851,353 shares
|
— | 30 Sep 2025 |
| ACORN CAPITAL ADVISORS, LLC |
13F
Company
|
1.8%
|
$199,434
586,572 shares
|
— | 30 Sep 2025 |
| Shay Capital LLC |
13F
Company
|
1.5%
|
$165,013
492,577 shares
|
— | 30 Sep 2025 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
1.3%
|
$148,000
446,414 shares
|
— | 30 Sep 2025 |
| Ikarian Capital, LLC |
13F
Company
|
0.87%
|
$97,149
290,000 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
39
Shares
8,179,397
Rows available
39
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
31
Q4 2025 holders
39
Holder diff
8
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend